C12N 2750/14333
Use of viral protein as therapeutic agent other than vaccine
Official title: Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
C12N2750/14333 (Use of viral protein as therapeutic agent other than vaccine) appears on 7 US grants and 10 published applications in this corpus.
Search patents in C12N- Granted patents
- 7
- Published applications
- 10
- Assignees
- 8
- Inventors
- 15
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 1 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 1 | 3 |
| 2017 | 1 | 0 |
| 2018 | 1 | 1 |
| 2019 | 0 | 1 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Recombinant adeno-associated virus delivery of exon 2-targeted U7SNRNA polynucleotide constructs16 Jun 2026US 12,655,427 B2Research Institute At Nationwide Children's Hospital
- Recombinant adeno-associated virus delivery of exon 2-targeted U7SNRNA polynucleotide constructs25 Jan 2022US 11,230,707 B2Research Institute At Nationwide Children's Hospital
- Chimeric adeno-associated virus/ bocavirus parvovirus vector6 Oct 2020US 10,793,835 B2University of Iowa Research Foundation
- Recombinant adeno-associated virus delivery of exon 2-targeted U7SNRNA polynucleotide constructs9 Jan 2018US 9,862,945 B2Research Institute At Nationwide Children's Hospital
- Chimeric adeno-associated virus/ bocavirus parvovirus vector28 Nov 2017US 9,828,587 B2University of Iowa Research Foundation
- Recombinant adeno-associated virus delivery of exon 2-targeted u7snrna polynucleotide constructs3 Sep 2026US 2026/0258419 A1Research Institute At Nationwide Children's Hospital
- Recombinant Adeno-Associated Virus Delivery of Exon 2-Targeted U7SNRNA Polynucleotide Constructs26 Jan 2023US 2023/0025574 A1Research Institute At Nationwide Children's Hospital
- Recombinant Adeno-Associated Virus Delivery of Exon 2-Targeted U7SNRNA Polynucleotide Constructs12 Sep 2019US 2019/0276822 A1Research Institute At Nationwide Children's Hospital
- Chimeric adeno-associated virus/ bocavirus parvovirus vector4 Oct 2018US 2018/0282702 A1University of Iowa Research Foundation
- Method for Cancer Therapy Based on Co-Administration of a Parvovirus and a Cytokine22 Dec 2016US 2016/0367609 A1Deutsches Krebsforschungszentrum Stiftung des Oeffentlichen Rechts
Most cited
By later US patents
- Chimeric adeno-associated virus/ bocavirus parvovirus vector9US 10,793,835 B2University of Iowa Research Foundation · 2020
- Chimeric adeno-associated virus/ bocavirus parvovirus vector8US 9,828,587 B2University of Iowa Research Foundation · 2017
- Recombinant adeno-associated virus delivery of exon 2-targeted U7SNRNA polynucleotide constructs8US 9,862,945 B2Research Institute At Nationwide Children's Hospital · 2018
- Recombinant adeno-associated virus delivery of exon 2-targeted U7SNRNA polynucleotide constructs3US 11,230,707 B2Research Institute At Nationwide Children's Hospital · 2022
- Use of parvovirus capsid particles in the inhibition of cell proliferation and migration2US 6,818,612 B22004